<http://purl.obolibrary.org/obo/GO_0006631>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/CHEBI_50906>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chemical role" .

<http://purl.obolibrary.org/obo/GO_0006644>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/145868002>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://model.geneontology.org/-1156210218> , <http://purl.obolibrary.org/obo/GO_0006631> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "The synthesis and breakdown of fatty acids are a central part of human energy metabolism, and the eicosanoid class of fatty acid derivatives regulate diverse processes in the body (Vance & Vance 2008 - URL). Processes annotated in this module include the synthesis of fatty acids from acetyl-CoA, mitochondrial and peroxisomal breakdown of fatty acids, and the metabolism of eicosanoids and related molecules." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Fatty acid metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                1450 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "Edited: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "https://reactome.org/content/detail/R-HSA-8957322" , "Reviewed: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0006629>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/GO_0042359>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.042559159947906045> , <http://model.geneontology.org/0.9350421635081183> , <http://model.geneontology.org/0.6479278432019226> , <http://model.geneontology.org/0.5353459992973865> , <http://model.geneontology.org/0.24356158991158405> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145868220> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868898>
] .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868099>
] .

<http://model.geneontology.org/0.12612445668653227>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:1390320" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0008202>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/0.4051400848898453>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:1390320" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/BFO_0000051>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has part" .

<http://purl.obolibrary.org/obo/RO_0000057>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has participant" .

<http://model.geneontology.org/0.7230514319683177>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15583024" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002327>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enables" .

<http://model.geneontology.org/145868933>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0046950> , <http://model.geneontology.org/-272274413> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Acetoacetate, beta-hydroxybutyrate, and acetone collectively are called ketone bodies. The first two are synthesized from acetyl-CoA, in the mitochondria of liver cells; acetone is formed by spontaneous decarboxylation of acetoacetate. Ketone body synthesis in liver is effectively irreversible because the enzyme that catalyzes the conversion of acetoacetate to acetoacetyl-CoA is not present in liver cells.<P>Ketone bodies, unlike fatty acids and triglycerides, are water-soluble. They are exported from the liver, and are taken up by other tissues, notably brain and skeletal and cardiac muscle. There, they are broken down to acetyl-CoA which is oxidized via the TCA cycle to yield energy. In a normal person, this pathway of ketone body synthesis and utilization is most active during extended periods of fasting. Under these conditions, mobilization and breakdown of stored fatty acids generates abundant acetyl-CoA acetyl-CoA in liver cells for synthesis of ketone bodies, and their utilization in other tissues minimizes the demand of these tissues for glucose (Sass 2011)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Ketone body metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                650 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Gopinathrao, G, 2003-07-16 00:00:00" , "Authored: Gopinathrao, G, 2003-07-23 10:32:00" , "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.6932011114362424>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15951480" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.org/pav/providedBy>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/0.3231671271285823>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:18974038" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002434>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "interacts with" .

<http://model.geneontology.org/145868001>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://model.geneontology.org/-1184839369> , <http://purl.obolibrary.org/obo/GO_0034389> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Lipid droplets (LDs) are cytosolic structures found in cells of all eukaryotes, comprising a monolayer of phospholipids surrounding a core of uncharged lipids such as triglyceride (TAG) and sterol esters. CIDEA, CIDEB and CIDEC were first studied for their roles in promotion of apoptosis but they are also known to play a role in energy metabolism. CIDEA and C bind to lipid droplets and regulate their enlargement, thereby restricting lipolysis and favouring storage (by promoting net neutral lipid transfer from smaller to larger lipid droplets) (Gao & Goodman 2015). LD formation involves the partitioning of neutral lipids from their site of synthesis at the endoplasmic reticulum (ER) to the cytosol. The fat storage-inducing transmembrane proteins 1 and 2 (FITM1 and FITM2), associated with the ER membrane, mediate binding and partitioning of TAGs into LDs. The short-chain dehydrogenases/reductases (SDR) family is a large family of NAD- or NADP-dependent oxidoreductase enzymes. 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) is a recently-discovered enzyme of unknown physiological function that is associated with lipid droplets and significantly upregulated in patients with nonalcoholic fatty liver disease. Hypoxia-inducible lipid droplet-associated protein (HILPDA) is a lipid droplet protein and stimulates intracellular lipid accumulation." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Lipid particle organization" ;
        <http://geneontology.org/lego/hint/layout/x>
                1650 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, Bijay, 2016-02-11" , "Reviewed: D'Eustachio, Peter, 2016-04-05" , "Authored: Jassal, Bijay, 2016-02-11" , "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/CHEBI_36080>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi protein" .

<http://purl.obolibrary.org/obo/RO_0002406>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly activates (process to process)" .

<http://purl.obolibrary.org/obo/BFO_0000002>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Continuant" .

<http://model.geneontology.org/0.24241354106673085>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15583024" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/145868221>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://model.geneontology.org/818606555> , <http://purl.obolibrary.org/obo/GO_0006695> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Cholesterol is synthesized de novo from acetyl CoA. The overall synthetic process is outlined in the attached illustration. Enzymes whose regulation plays a major role in determining the rate of cholesterol synthesis in the body are highlighted in red, and connections to other metabolic processes are indicated. The transformation of zymosterol into cholesterol can follow either of routes, one in which reduction of the double bond in the isooctyl side chain is the final step (cholesterol synthesis via desmosterol, also known as the Bloch pathway) and one in which this reduction is the first step (cholesterol biosynthesis via lathosterol, also known as the Kandutsch-Russell pathway). The former pathway is prominent in the liver and many other tissues while the latter is prominent in skin, where it may serve as the source of the 7-dehydrocholesterol that is the starting point for the synthesis of D vitamins. Defects in several of the enzymes involved in this process are associated with human disease and have provided useful insights into the regulatory roles of cholesterol and its synthetic intermediates in human development (Gaylor 2002; Herman 2003; Kandutsch & Russell 1960; Mitsche et al. 2015; Song et al. 2005)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Cholesterol biosynthesis" ;
        <http://geneontology.org/lego/hint/layout/x>
                850 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: D'Eustachio, P, 2007-01-22 01:32:07" , "Authored: Jassal, B, 2007-01-24 15:15:12" , "Edited: D'Eustachio, P, 2007-01-22 01:29:56" , "https://reactome.org/content/detail/R-HSA-8957322" , "Reviewed: Jassal, Bijay, 2015-11-02" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002334>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "regulated by" .

<http://purl.obolibrary.org/obo/GO_0008150>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Biological Process" .

<http://model.geneontology.org/-300903564>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Wax biosynthesis" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.4749048809154722> , <http://model.geneontology.org/0.6264244613594434> , <http://model.geneontology.org/0.44998069285815956> , <http://model.geneontology.org/0.862870750704604> , <http://model.geneontology.org/0.9997191183074716> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145868220> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868224>
] .

<http://purl.obolibrary.org/obo/BFO_0000015>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Process" .

<http://model.geneontology.org/145868096>
        a       <http://model.geneontology.org/1534929976> , <http://purl.obolibrary.org/obo/GO_0006641> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Fatty acids derived from the diet and synthesized de novo in the liver are assembled into triglycerides (triacylglycerols) for transport and storage. Synthesis proceeds in steps of conversion of fatty acyl-CoA to phosphatidic acid, conversion of phosphatidic acid to diacylglycerol, and conversion of diacylglycerol to triacylglycerol (Takeuchi & Reue 2009).<br>Hydrolysis of triacylglycerol to yield fatty acids and glycerol is a tightly regulated part of energy metabolism. A central part in this regulation is played by hormone-sensitive lipase (HSL), a neutral lipase abundant in adipocytes and skeletal and cardiac muscle, but also abundant in ovarian and adrenal tissue, where it mediates cholesterol ester hydrolysis, yielding cholesterol for steroid biosynthesis. The hormones to which it is sensitive include catecholamines (e.g., epinephrine), ACTH, and glucagon, all of which trigger signaling cascades that lead to its phosphorylation and activation, and insulin, which sets off events leading to its dephosphorylation and inactivation (Kraemer & Shen 2002).<p>The processes of triacylglycerol and cholesterol ester hydrolysis are also regulated by subcellular compartmentalization: these lipids are packaged in cytosolic particles and the enzymes responsible for their hydrolysis, and perhaps for additional steps in their metabolism, are organized at the surfaces of these particles (e.g., Brasaemle et al. 2004)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Triglyceride metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                2250 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "https://reactome.org/content/detail/R-HSA-8957322" , "Edited: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "Reviewed: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868096>
] .

<http://model.geneontology.org/0.5658641732443729>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:12543708" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-1242097671>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/RO_0002234>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has output" .

<http://purl.obolibrary.org/obo/RO_0002413>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly provides input for (process to process)" .

<http://purl.obolibrary.org/obo/CHEBI_24431>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chemical entity" .

<http://model.geneontology.org/704089951>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Sphingolipid metabolism" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/0.36478271557637887>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:12543708" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/BFO_0000050>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "part of" .

<http://model.geneontology.org/0.9997191183074716>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15583024" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.9350421635081183>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15951480" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.6479278432019226>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:1390320" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/145868932>
        a       <http://purl.obolibrary.org/obo/GO_0010025> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://model.geneontology.org/-300903564> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Waxes are esters of long chain fatty acids and long chain fatty alcohols that play an important role in protecting the skin surface from drying and abrasion. Enzymes that catalyze two reactions of wax biosynthesis have been characterized in humans. FAR1 and FAR2 catalyze the reduction of fatty acids to fatty alcohols in the peroxisome and AWAT1 and AWAT2 catalyze the reaction of fatty alcohols and acyl-CoA in the cytosol to form wax esters. The existence of a transport process, otherwise uncharacterized, to move fatty alcohols from the peroxisome to the cytosol is inferred from the observation that cultured cells that do not normally synthesize waxes can be induced to do so by co-transfection with DNA constructs encoding FAR and AWAT enzymes (Cheng & Russell 2004a,b)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Wax biosynthesis" ;
        <http://geneontology.org/lego/hint/layout/x>
                850 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Jassal, Bijay, 2016-01-29" , "Edited: D'Eustachio, Peter, 2015-12-09" , "Authored: D'Eustachio, Peter, 2015-12-09" , "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/145868904>
        a       <http://purl.obolibrary.org/obo/GO_0008202> , <http://model.geneontology.org/-1102519792> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Steroid hormones are synthesized primarily in the adrenal gland and gonads. They regulate energy metabolism and stress responses (glucocorticoids), salt balance (mineralocorticoids), and sexual development and function (androgens and estrogens). All steroids are synthesized from cholesterol. Steroid hormone synthesis is largely regulated at the initial steps of cholesterol mobilization and transport into the mitochondrial matrix for conversion to pregnenolone. In the body, the fate of pregnenolone is tissue-specific: in the zona fasciculata of the adrenal cortex it is converted to cortisol, in the zona glomerulosa to aldosterone, and in the gonads to testosterone and then to estrone and estradiol. These pathways are outlined in the figure below, which also details the sites on the cholesterol molecule that undergo modification in the course of these reactions." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism of steroid hormones" ;
        <http://geneontology.org/lego/hint/layout/x>
                1050 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: D'Eustachio, P, 2007-04-20 21:11:21" , "Edited: Jassal, B, 2007-04-20 21:09:56" , "https://reactome.org/content/detail/R-HSA-8957322" , "Authored: Jassal, B, 2007-04-20 21:09:56" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0032991>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "protein-containing complex" .

<http://purl.org/dc/elements/1.1/source>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/0.6264244613594434>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:12543708" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868932>
] .

<http://model.geneontology.org/145868220>
        a       <http://purl.obolibrary.org/obo/GO_0008150> , <http://model.geneontology.org/789977404> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008202> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "http://www.reactome.org" , "Steroids, defined by a four-ring cyclopenta[a]phenanthrene carbon skeleton, include cholesterol and bile acids and salts, steroid hormones, and vitamin D, three groups of molecules synthesized from it. In this module, pathways for the synthesis of cholesterol from HMG-CoA (hydroxymethylglutaryl-coenzyme A) (Russell 1992), and for its conversion to bile acids and salts (Russell 2003), steroid hormones (Payne & Hales 2004), and vitamin D (Dusso et al. 2005) are annotated, together with the SREBP-mediated regulatory process that normally links the rate of cholesterol synthesis to levels of cellular cholesterol (Brown & Goldstein 2009)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism of steroids" ;
        <http://geneontology.org/lego/hint/layout/x>
                1850 , 20 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.obolibrary.org/obo/BFO_0000050>
                <http://model.geneontology.org/145867998> ;
        <http://purl.obolibrary.org/obo/BFO_0000051>
                <http://model.geneontology.org/145868224> , <http://model.geneontology.org/145868931> , <http://model.geneontology.org/145868898> , <http://model.geneontology.org/145868904> , <http://model.geneontology.org/145868221> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, B, 2007-01-24 15:15:12" , "https://reactome.org/content/detail/R-HSA-8957322" , "Authored: Jassal, B, 2007-01-24 15:15:12" , "Reviewed: Jassal, Bijay, 2015-11-02" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0008206>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/RO_0002333>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enabled by" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.957729053562516> , <http://model.geneontology.org/0.13455600524233857> , <http://model.geneontology.org/0.4742437678682505> , <http://model.geneontology.org/0.12612445668653227> , <http://model.geneontology.org/0.36478271557637887> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145868220> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868221>
] .

<http://model.geneontology.org/0.2523516292163137>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15951480" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002305>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "causally upstream of with a negative effect" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868002>
] .

<http://purl.obolibrary.org/obo/RO_0002233>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has input" .

<http://model.geneontology.org/0.77774978972286>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:18974038" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0010025>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/0.5353459992973865>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15583024" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.3642639025306028>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:18974038" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://geneontology.org/lego/hint/layout/y>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/0.4742437678682505>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:18974038" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/145867999>
        a       <http://purl.obolibrary.org/obo/GO_0019216> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://model.geneontology.org/-1242097671> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Peroxisome proliferator-activated receptor alpha (PPAR-alpha) is the major regulator of fatty acid oxidation in the liver. PPARalpha is also the target of fibrate drugs used to treat abnormal plasma lipid levels. <br>PPAR-alpha is a type II nuclear receptor (its subcellular location does not depend on ligand binding). PPAR-alpha forms heterodimers with Retinoid X receptor alpha (RXR-alpha), another type II nuclear receptor. PPAR-alpha is activated by binding fatty acid ligands, especially polyunsaturated fatty acids having 18-22 carbon groups and 2-6 double bonds. <br>The PPAR-alpha:RXR-alpha heterodimer binds peroxisome proliferator receptor elements (PPREs) in and around target genes. Binding of fatty acids and synthetic ligands causes a conformational change in PPAR-alpha such that it releases the corepressors and binds coactivators (CBP-SRC-HAT complex, ASC complex, and TRAP-Mediator complex) which initiate transcription of the target genes.<br>Target genes of PPAR-alpha participate in fatty acid transport, fatty acid oxidation, triglyceride clearance, lipoprotein production, and cholesterol homeostasis." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)" ;
        <http://geneontology.org/lego/hint/layout/x>
                450 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: May, B, 2009-06-08" , "Edited: May, B, 2011-11-08" , "Authored: May, B, 2009-05-30 16:45:51" , "https://reactome.org/content/detail/R-HSA-8957322" , "Reviewed: Kersten, S, 2009-06-08" , "Edited: May, B, 2009-05-30 16:45:51" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/675460800>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Plasmalogen biosynthesis" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/145868931>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0042359> , <http://model.geneontology.org/-329532715> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Vitamin D3 (VD3, cholecalciferol) is a steroid hormone that principally plays roles in regulating intestinal calcium absorption and in bone metabolism. It is obtained from the diet and produced in the skin by photolysis of 7-dehydrocholesterol and released into the bloodstream. Very few foods (eg. oily fish, mushrooms exposed to sunlight and cod liver oil) are natural sources of vitamin D. A small number of countries in the world artificially fortify a few foods with vitamin D. The metabolites of vitamin D are carried in the circulation bound to a plasma protein called vitamin D binding protein (GC) (for review see Delanghe et al. 2015, Chun 2012). Vitamin D undergoes two subsequent hydroxylations to form the active form of the vitamin, 1-alpha, 25-dihydroxyvitamin D (1,25(OH)2D). The first hydroxylation takes place in the liver followed by subsequent transport to the kidney where the second hydroxylation takes place. 1,25(OH)2D acts by binding to nuclear vitamin D receptors (Neme et al. 2017) and it has been estimated that upwards of 2000 genes are directly or indirectly regulated which are involved in calcium homeostasis, immune responses, cellular growth, differentiation and apoptosis (Hossein-nezhad et al. 2013, Hossein-nezhad & Holick 2013). Inactivation of 1,25(OH)2D occurs via C23/C24 oxidation catalysed by cytochrome CYP24A1 enzyme (Christakos et al. 2016)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Vitamin D (calciferol) metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                450 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, Bijay, 2008-10-01" , "https://reactome.org/content/detail/R-HSA-8957322" , "Edited: Jassal, B, 2008-06-02 10:50:11" , "Reviewed: D'Eustachio, P, 2008-05-28 08:30:54" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868220>
] .

<http://purl.obolibrary.org/obo/GO_0006641>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/0.24356158991158405>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:12543708" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0006695>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.8622126362154207> , <http://model.geneontology.org/0.6777605237891606> , <http://model.geneontology.org/0.3231671271285823> , <http://model.geneontology.org/0.06532096270812582> , <http://model.geneontology.org/0.9599315477344775> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000050> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145868220> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145867998>
] .

<http://purl.obolibrary.org/obo/RO_0002304>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "causally upstream of with a positive effect" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868001>
] .

<http://model.geneontology.org/0.8622126362154207>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:1390320" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/145868898>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008206> , <http://model.geneontology.org/-1274294698> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "In a healthy adult human, about 500 mg of cholesterol is converted to bile salts daily. Newly synthesized bile salts are secreted into the bile and released into the small intestine where they emulsify dietary fats (Russell 2003). About 95% of the bile salts in the intestine are recovered and returned to the liver (Kullak-Ublick et al. 2004; Trauner and Boyer 2002). The major pathway for bile salt synthesis in the liver begins with the conversion of cholesterol to 7alpha-hydroxycholesterol. Bile salt synthesis can also begin with the synthesis of an oxysterol - 24-hydroxycholesterol or 27-hydroxycholesterol. In the body, the initial steps of these two pathways occur in extrahepatic tissues, generating intermediates that are transported to the liver and converted to bile salts via the 7alpha-hydroxycholesterol pathway. These extrahepatic pathways contribute little to the total synthesis of bile salts, but are thought to play important roles in extrahepatic cholesterol homeostasis (Javitt 2002)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Bile acid and bile salt metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                250 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: D'Eustachio, P, 2007-04-30 14:43:26" , "Reviewed: D'Eustachio, P, 2007-04-30 14:43:26" , "https://reactome.org/content/detail/R-HSA-8957322" , "Authored: Jassal, Bijay, 2007-01-19" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.042559159947906045>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:18974038" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/145868217>
        a       <http://model.geneontology.org/704089951> , <http://purl.obolibrary.org/obo/GO_0006665> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Sphingolipids are derivatives of long chain sphingoid bases such as sphingosine (trans-1,3-dihydroxy 2-amino-4-octadecene), an 18-carbon unsaturated amino alcohol which is the most abundant sphingoid base in mammals. Amide linkage of a fatty acid to sphingosine yields ceramides. Esterification of phosphocholine to ceramides yields sphingomyelin, and ceramide glycosylation yields glycosylceramides. Introduction of sialic acid residues yields gangliosides. These molecules appear to be essential components of cell membranes, and intermediates in the pathways of sphingolipid synthesis and breakdown modulate processes including apoptosis and T cell trafficking.<p>While sphingolipids are abundant in a wide variety of foodstuffs, these dietary molecules are mostly degraded by the intestinal flora and intestinal enzymes. The body primarily depends on de novo synthesis for its sphingolipid supply (Hannun and Obeid 2008; Merrill 2002). De novo synthesis proceeds in four steps: the condensation of palmitoyl-CoA and serine to form 3-ketosphinganine, the reduction of 3-ketosphinganine to sphinganine, the acylation of sphinganine with a long-chain fatty acyl CoA to form dihydroceramide, and the desaturation of dihydroceramide to form ceramide.<p>Other sphingolipids involved in signaling are derived from ceramide and its biosynthetic intermediates. These include sphinganine (dihydrosphingosine) 1-phosphate, phytoceramide, sphingosine, and sphingosine 1-phosphate.<p>Sphingomyelin is synthesized in a single step in the membrane of the Golgi apparatus from ceramides generated in the endoplasmic reticulum (ER) membrane and transferred to the Golgi by CERT (ceramide transfer protein), an isoform of COL4A3BP that is associated with the ER membrane as a complex with PPM1L (protein phosphatase 1-like) and VAPA or VAPB (VAMP-associated proteins A or B). Sphingomyelin synthesis appears to be regulated primarily at the level of this transport process through the reversible phosphorylation of CERT (Saito et al. 2008).<br>" ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Sphingolipid metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                1050 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Jassal, B, 2009-08-20" , "https://reactome.org/content/detail/R-HSA-8957322" , "Authored: D'Eustachio, P, 2009-08-20" , "Edited: D'Eustachio, P, 2009-08-20" , "Reviewed: Hannun, YA, Luberto, C, 2009-11-18" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.6777605237891606>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15951480" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002411>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "causally upstream of" .

<http://purl.obolibrary.org/obo/GO_0005575>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Cellular Component" .

<http://model.geneontology.org/145868936>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0050728> , <http://model.geneontology.org/-186386960> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "A host’s normal protective response to tissue injury or pathogenic infection is acute inflammation. The condition of acute inflammation is created by the release of pro-inflammatory lipid mediators such as leukotrienes (LTs) and prostaglandins (PGs) that launch a series of signaling cascades to destroy invading pathogens and to repair damaged tissue (Libby 2007). The potent chemotactic agent leukotriene B4 (LTB4) promotes the recruitment of neutrophils (PMNs) to inflamed tissues, while the prostaglandins E2 and D2 (PGE2 and PGD2) further accelerate the inflammatory process. If left unchecked, the inflammatory response can initiate chronic systemic inflammatory disorders associated with cardiovascular disease, rheumatoid arthritis, periodontal disease, asthma, diabetes, inflammatory bowel disease (IBD), Alzheimer’s disease and age-related macular degeneration (AMD). The specific role by which inflammation contributes to their pathogenesis is not fully understood.<br><br>To prevent the onset of chronic inflammation, a <i>lipid mediator class switch</i> is thought to occur from the initial actions of pro-inflammatory lipid mediators to the anti-inflammatory and pro-resolving actions of lipoxins, resolvins, protectins and maresins (collectively called specialized proresolving mediators (SPMs)). Nanopicogram quantities of different lipid mediators are generated at different times during the evolution of the inflammatory response and these mediators coincide with distinct cellular events. The class switch activates leukocyte translational regulation of the enzymes required to produce pro-resolving lipid mediators (Levy et al. 2001). Each family of these PSMs exert specialized actions, including blocking neutrophil recruitment, promoting the recruitment and activation of monocytes, as well as mediating the nonphlogistic phagocytosis and lymphatic clearance of apoptotic neutrophils by activated macrophages (ie without inducing inflammation) and mediating tissue regeneration. Eventually, through the combined actions of these mediators, the resolution of inflammation is completed and homeostasis is reached (Serhan 2010, Bannenberg & Serhan 2010, Freire & Van Dyke 2013, Serhan et al. 2014).<br><br>SPMs are derived from polyunsaturated fatty acids (PUFAs) (Molfino et al. 2017). PUFAs of the ω-3 series are essential nutrients since they cannot be produced by humans (Duvall & Levy 2016) and are primarily found in dietary fish oils (Calder 2013) and in plants (Baker et al. 2016). The ω-3 PUFAs eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAn-3) circulate in the bloodstream after dietary intake and are easily incorporated into cellular membranes in a time- and dose-dependent manner (Calder 2009), as well as being present in inflammatory exudates (Kasuga et al. 2008). They can be mobilised by phospholipase A2 from cellular membranes on injury or infection when they are converted to exudate SPMs (Serhan et al. 2002) to interact with local immune cells (Kasuga et al. 2008). EPA is the source for E-series resolvins while DHA is the source for D-series resolvins, protectins, maresins and sulfido conjugates in tissue regeneration mediators (Serhan et al. 2017). The ω-6 fatty acid arachidonic acid (AA) is the source for lipoxins. ω-3 or ω-6 PUFA docosapentaenoic acids (DPAn-3 and DPAn-6) are the sources of DPA-derived resolvins, protectins and maresins (Vik et al. 2017). Aspirin can also trigger the production of epimeric SPMs via acetylated PTGS2 (prostaglandin G/H synthase, COX2) (Serhan & Chiang 2002). Combinations of oxidation, reduction and hydrolysis can generate numerous SPMs. Electrophilic oxo-derivatives of ω-3 PUFAs are a class of oxidised derivatives that are generated in macrophages and neutrophils by the actions of 5-lipoxygenase, cyclooxygenase-2 and acetylated cyclooxygenase-2, followed by dehydrogenation. Being electrophilic, oxo-derivative SPMs reversibly bind to nucleophilic residues on target proteins, triggering the activation of cytoprotective pathways (Cipollina 2015). The pathways in this section describe the biosynthesis of these SPMs." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Biosynthesis of specialized proresolving mediators (SPMs)" ;
        <http://geneontology.org/lego/hint/layout/x>
                250 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, Bijay, 2017-09-04" , "https://reactome.org/content/detail/R-HSA-8957322" , "Edited: Jassal, Bijay, 2017-09-04" , "Reviewed: Hansen, Trond Vidar, 2018-02-21" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-1102519792>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism of steroid hormones" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/GO_0034389>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://geneontology.org/lego/hint/layout/x>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/GO_0019216>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/904494008>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Regulation of cholesterol biosynthesis by SREBP (SREBF)" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://geneontology.org/lego/evidence>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/145867998>
        a       <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0006629> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Lipids are hydrophobic but otherwise chemically diverse molecules that play a wide variety of roles in human biology. They include ketone bodies, fatty acids, triacylglycerols, phospholipids and sphingolipids, eicosanoids, cholesterol, bile salts, steroid hormones, and fat-soluble vitamins. They function as a major source of energy (fatty acids, triacylglycerols, and ketone bodies), are major constituents of cell membranes (cholesterol and phospholipids), play a major role in their own digestion and uptake (bile salts), and participate in numerous signaling and regulatory processes (steroid hormones, eicosanoids, phosphatidylinositols, and sphingolipids) (Vance & Vance 2008 - URL).<p>The central steroid in human biology is cholesterol, obtained from animal fats consumed in the diet or synthesized de novo from acetyl-coenzyme A. (Vegetable fats contain various sterols but no cholesterol.) Cholesterol is an essential constituent of lipid bilayer membranes and is the starting point for the biosyntheses of bile acids and salts, steroid hormones, and vitamin D. Bile acids and salts are mostly synthesized in the liver. They are released into the intestine and function as detergents to solubilize dietary fats. Steroid hormones are mostly synthesized in the adrenal gland and gonads. They regulate energy metabolism and stress responses (glucocorticoids), salt balance (mineralocorticoids), and sexual development and function (androgens and estrogens). At the same time, chronically elevated cholesterol levels in the body are associated with the formation of atherosclerotic lesions and hence increased risk of heart attacks and strokes. The human body lacks a mechanism for degrading excess cholesterol, although an appreciable amount is lost daily in the form of bile salts and acids that escape recycling.<p>Aspects of lipid metabolism currently annotated in Reactome include lipid digestion, mobilization, and transport; fatty acid, triacylglycerol, and ketone body metabolism; peroxisomal lipid metabolism; phospholipid and sphingolipid metabolism; cholesterol biosynthesis; bile acid and bile salt metabolism; and steroid hormone biosynthesis." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism of lipids" ;
        <http://geneontology.org/lego/hint/layout/x>
                20 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.obolibrary.org/obo/BFO_0000051>
                <http://model.geneontology.org/145868933> , <http://model.geneontology.org/145868217> , <http://model.geneontology.org/145868932> , <http://model.geneontology.org/145868001> , <http://model.geneontology.org/145868096> , <http://model.geneontology.org/145868099> , <http://model.geneontology.org/145868220> , <http://model.geneontology.org/145867999> , <http://model.geneontology.org/145868936> , <http://model.geneontology.org/145868002> , <http://model.geneontology.org/145868216> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "https://reactome.org/content/detail/R-HSA-8957322" , "Edited: D'Eustachio, P, Joshi-Tope, G, 0000-00-00 00:00:00" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0045540>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/GO_0008611>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/145868224>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0045540> , <http://model.geneontology.org/904494008> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Sterol regulatory element binding proteins (SREBPs, SREBFs) respond to low cholesterol concentrations by transiting to the nucleus and activating genes involved in cholesterol and lipid biosynthesis (reviewed in Brown and Goldstein 2009, Osborne and Espenshade 2009, Weber et al. 2004).<br> Newly synthesized SREBPs are transmembrane proteins that bind SCAP in the endoplasmic reticulum (ER) membrane. SCAP binds cholesterol which causes a conformational change that allows SCAP to interact with INSIG, retaining the SCAP:SREBP complex in the ER. INSIG binds oxysterols, which cause INSIG to bind SCAP and retain SCAP:SREBP in the endoplasmic reticulum.<br>In low cholesterol (below about 5 mol%) SCAP no longer interacts with cholesterol or INSIG and binds Sec24 of the CopII coat complex instead. Thus SCAP:SREBP transits with the CopII complex from the ER to the Golgi. In the Golgi SREBP is cleaved by S1P and then by S2P, releasing the N-terminal fragment of SREBP into the cytosol. The N-terminal fragment is imported to the nucleus by importin-beta and then acts with other factors, such as SP1 and NF-Y, to activate transcription of target genes. Targets of SREBP include the genes encoding all enzymes of cholesterol biosynthesis and several genes involved in lipogenesis. SREBP2 most strongly activates cholesterol biosynthesis while SREBP1C most strongly activates lipogenesis." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Regulation of cholesterol biosynthesis by SREBP (SREBF)" ;
        <http://geneontology.org/lego/hint/layout/x>
                650 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Liang, Guosheng, 2012-08-25" , "https://reactome.org/content/detail/R-HSA-8957322" , "Edited: May, B, 2011-10-13" , "Authored: May, B, 2011-09-28" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002629>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly positively regulates" .

<http://purl.org/dc/elements/1.1/date>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.7230514319683177> , <http://model.geneontology.org/0.5599542479972496> , <http://model.geneontology.org/0.2523516292163137> , <http://model.geneontology.org/0.3642639025306028> , <http://model.geneontology.org/0.5658641732443729> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145868220> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868931>
] .

<http://model.geneontology.org/145868099>
        a       <http://purl.obolibrary.org/obo/GO_0006644> , <http://model.geneontology.org/1620817429> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Phospholipids contain a polar head group and two long-chain fatty acyl moieties, one of which is generally unsaturated. The head group is a glycerol or serine phosphate attached to a polar group such as choline. These molecules are a major constituent of cellular membranes, where their diverse structures and asymmetric distributions play major roles in determining membrane properties (Dowhan 1997). The four major classes of phospholipids in human plasma membranes are phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine, and sphingomyelin. The first three are derivatives of glycerol while sphingomyelin is a derivative of serine.<p>Here, pathways for the metabolism of glycerophospholipids, phosphphatidylinositol (PI), and sphingolipids are annotated." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Phospholipid metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                2050 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Williams, MG, 2011-09-09" , "Reviewed: D'Eustachio, P, 2012-05-19" , "Authored: Williams, MG, 2011-08-12" , "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868217>
] .

<http://geneontology.org/lego/modelstate>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/CHEBI_33695>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi gene" .

<http://purl.obolibrary.org/obo/RO_0001025>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "located in" .

<http://purl.obolibrary.org/obo/ECO_0000313>
        a       <http://www.w3.org/2002/07/owl#Class> .

<http://purl.obolibrary.org/obo/GO_0003674>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Molecular Function" .

<http://purl.obolibrary.org/obo/GO_0050728>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/-1156210218>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Fatty acid metabolism" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868936>
] .

<http://purl.obolibrary.org/obo/RO_0002429>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in positive regulation_of" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145867999>
] .

<http://purl.obolibrary.org/obo/RO_0000087>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has role" .

<http://model.geneontology.org/818606555>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Cholesterol biosynthesis" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/145868216>
        a       <http://model.geneontology.org/675460800> , <http://purl.obolibrary.org/obo/GO_0008611> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "1-Acylglycerol-3-phosphate is synthesized from dihydroxyacetone phosphate, an acyl CoA molecule and NADPH + H+ in four reactions catalyzed by peroxisomal enzymes, either in the matrix of the organelle or associated with its membrane. These reactions are annotated here for palmityl (C16:0) CoA. In a series of less well-characterized reactions in the cytosol and endoplasmic reticulum, these molecules are converted to ether lipids (plasmalogens). The functions of plasmalogens are not well understood. They are an abundant subclass of phospholipids, however, and defects in their metabolism are associated with serious human disease (de Vet et al. 1999; Nagan and Zoeller 2001)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Plasmalogen biosynthesis" ;
        <http://geneontology.org/lego/hint/layout/x>
                1250 ;
        <http://geneontology.org/lego/hint/layout/y>
                20 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: D'Eustachio, P, 2009-02-11 15:12:47" , "Reviewed: Jassal, Bijay, 2009-02-27" , "Edited: D'Eustachio, P, 2009-03-18 13:33:40" , "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002024>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly positively regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000066>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "occurs in" .

<http://model.geneontology.org/0.4749048809154722>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15951480" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-329532715>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Vitamin D (calciferol) metabolism" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/RO_0002630>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly negatively regulates" .

<http://model.geneontology.org/0.44998069285815956>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:18974038" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.06532096270812582>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15583024" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/0.9599315477344775>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:12543708" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.org/dc/elements/1.1/contributor>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002408>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly inhibits (process to process)" .

<http://model.geneontology.org/0.957729053562516>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15583024" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-186386960>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Biosynthesis of specialized proresolving mediators (SPMs)" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/0.5599542479972496>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:1390320" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/443771583>
        a       <http://www.w3.org/2002/07/owl#Ontology> ;
        <http://geneontology.org/lego/modelstate>
                "development" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/title>
                "Reactome:unexpanded:Metabolism of steroids" .

<http://model.geneontology.org/0.862870750704604>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:1390320" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-1184839369>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Lipid particle organization" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.6932011114362424> , <http://model.geneontology.org/0.77774978972286> , <http://model.geneontology.org/0.24241354106673085> , <http://model.geneontology.org/0.4051400848898453> , <http://model.geneontology.org/0.15846296691566275> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145868220> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868904>
] .

<http://model.geneontology.org/1534929976>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Triglyceride metabolism" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868216>
] .

<http://purl.obolibrary.org/obo/RO_0002430>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in negative regulation_of" .

<http://model.geneontology.org/-272274413>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Ketone body metabolism" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/0.15846296691566275>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:12543708" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/789977404>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism of steroids" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://model.geneontology.org/1620817429>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Phospholipid metabolism" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.org/dc/elements/1.1/title>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/GO_0006665>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-8957322" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-10-04" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/145867998> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/145868933>
] .

<http://model.geneontology.org/0.13455600524233857>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-8957322" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-10-04" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:15951480" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002428>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in regulation of" .

<http://model.geneontology.org/-1274294698>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Bile acid and bile salt metabolism" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/RO_0002023>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly negatively regulated by" .

<http://purl.obolibrary.org/obo/GO_0046950>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/RO_0002328>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "functionally related to" .
